Phone (336) 292-1510
Fax (336) 292-0679

Receive our eNewsletter

  Home  
  Our Team  
  Patient Info  
  Services  

News for Healthier Living

Study identifies weight-loss drug target in the brain

A team led by researchers from UT Southwestern Medical Center and a university in South Korea has identified a subset of brain cells whose activation may be partially responsible for the effects of a popular class of weight loss drugs that includes semaglutide and tirzepatide. Their findings, published in Science, could eventually help scientists optimize the efficacy of these drugs, known as glucagon-like peptide-1 receptor agonists (GLP-1RAs).

August 8, 2024


March 20 2026

March 19 2026

March 18 2026

March 17 2026

March 16 2026

March 15 2026

March 14 2026

March 13 2026

March 12 2026

March 11 2026

March 10 2026

March 9 2026

March 8 2026

March 7 2026